Discovery of deregulation of zinc homeostasis and its associated genes in esophageal squamous cell carcinoma using cDNA microarray

International Journal of Cancer

Volumn 120, Issue 2, 2007, Pages 230-242

  Kumar, Anupam ^a   Chatopadhyay, Tusharkant ^a   Raziuddin, Mohamad ^b   Ralhan, Ranju ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b VINOBA BHAVE UNIVERSITY   (India)

Author keywords

cDNA microarray; Esophageal squamous cell carcinoma; Real time quantitative RT PCR; Tissue microarray; Zinc homeostasis

Indexed keywords

CELL PROTEIN; CELLULAR MODULATOR OF IMMUNE RECOGNITION PROTEIN; COMPLEMENTARY DNA; METALLOTHIONEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 3; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TRANSCRIPTION FACTOR SLUG; UBIQUITIN; ZINC; ZINC FINGER PROTEIN; ZINC TRANSPORTER;

ARTICLE; BIDI SMOKING; CIGARETTE SMOKING; DNA MICROARRAY; DOWN REGULATION; DRINKING BEHAVIOR; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC CODE; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDIAN; LOWEST INCOME GROUP; NUCLEOTIDE SEQUENCE; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; TISSUE MICROARRAY; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE; UPREGULATION;

CARCINOMA, SQUAMOUS CELL; CATION TRANSPORT PROTEINS; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEOSTASIS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METALLOTHIONEIN; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, NEOPLASM; TUMOR CELLS, CULTURED; ZINC; ZINC FINGERS;

EID: 33845655640     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22246     Document Type: Article

References (78)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Malkan G, Mohandas KM. Epidemiology of digestive cancers in India. I. General principles and esophageal cancer. Indian J Gastroenterol 1997;3:98-102.
3. Nayar D, Kapif U, Joshi YK, Sundaram KR, Srivastava SP, Shukla NK, Tandon RK. Nutritional risk factors in esophageal cancer. J Assoc Physicians India 2000;8:781-7.
4. Phukan RK, Chetia CK, Ali MS, Mahanta J. Role of dietary habits in the development of esophageal cancer in Assam, the north-eastern region of India. Nutr Cancer 2001;2:204-9.
5. Gajalakshmi V, Swaminathan R, Shanta V. An independent survey to assess completeness of registration: population based cancer registry, Chennai, India. Asian Pac J Cancer Prev 2001;3:179-83.
6. Montesano R, Hollstein M, Hainaut P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 1996;3:225-35.
7. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;2:153-6.
8. Gupta NM, Jindal R, Prakash O, Gupta R, Bhasin DK. Comparison of the clinical profile and outcome for squamous cell carcinoma and adenocarcinoma of the distal esophagus and cardia in India. Surg Today 2001;5:400-4.
9. Yeole BB, Kumar AV. Population-based survival from cancers having a poor prognosis in Mumbai (Bombay). India. Asian Pac J Cancer Prev 2004;2:175-82.
10. Srivastava M, Kapil U, Chattopadhyay TK, Shukla NK, Sundaram KR, Sekaran G, Nayar D. Nutritional factors in carcinoma oesophagus: a case-control study. Asia Pacific J Clin Nutr 1997;2:s96-8.
11. Kapil U, Srivastav M, Nayar D. Vitamin 'A' and oesophageal cancer. Trop Gastroenterol 1993;3:87-90.
12. Nayar D, Kapil U, Joshi YK, Sundaram KR, Srivastava SP, Shukla NK, Tandon RK. Association of vitamin A, zinc, selenium and magnesium with oesophageal cancer. Trop Gastroenterol 1998;4:148-9.
13. Liu CG, Zhang L, Jiang Y, Chatterjce D, Croce CM, Huebner K, Fong LY. Modulation of gene expression in precancerous rat esophagus by dietary zinc deficit and replenishment. Cancer Res 2005;17:7790-9.
14. Lonnerdal B. Dietary factors influencing zinc absorption. J Nutr 2000;5S:1378S-83S.
15. Abnet CC, Lai B, Qiao YL, Vogt S, Luo XM, Taylor PR, Dong ZW, Mark SD, Dawsey SM. Zinc concentration in esophageal biopsy specimens measured by x-ray fluorescence and esophageal cancer risk. J Natl Cancer Inst 2005;4:301-6.
16. Cousins RJ, Blanchard RK, Moore JB, Cui L, Green CL, Liuzzi JR Cao J, Bobo JA. Regulation of zinc metabolism and genomic outcomes. J Nutr 2003;5S1521S-6S.
17. Fong LY, Lau KM, Huebner K, Magee PN. Induction of esophageal tumors in zinc-deficient rats by single low doses of N-nitrosomethylbhenzylamine (NMBA): analysis of cell proliferation, and mutations in H-ras and p53 genes. Carcinogenesis 1997;8:1477-84.
18. Stepanov I, Hecht SS, Ramakrishnan S, Gupta PC. Tobacco-specific nitrosamines in smokeless tobacco products marketed in India. Int J Cancer 2005;1:16-19.
19. Lu J, Liu Z, Xiong M, Wang Q, Wang X, Yang G, Zhao L, Qiu Z, Zhou C, Wu M. Gene expression profile changes in initiation and progression of squamous cell carcinoma of esophagus. Int J Cancer 2001;3:288-94.
20. Hu YC, Lam KY, Law S, Wong J, Srivastava G. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1. Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res 2001;8:2213-21.
21. Kan T, Shimada Y, Sato F, Maeda M, Kawabe A, Kaganoi J, Itami A, Yamasaki S, Imamura M. Gene expression profiling in human esophageal cancers using cDNA microarray. Biochem Biophys Res Commun 2001;4:792-801.
22. Zhou J, Zhao LQ, Xiong MM, Wang XQ, Yang GR, Qiu ZL, Wu M, Lia ZH. Gene expression profiles at different stages of human esophageal squamous cell carcinoma. World J Gastroenterol 2003;1:9-13.
23. Xu SH, Qian LJ, Mou HZ, Zhu CH, Zhou XM, Lin XL, Chen Y, Bao WY. Difference of gene expression profiles between esophageal carcinoma and its pericancerous epithelium by gene chip. World J Gastroenterol 2003;3:417-22.
24. Kan T, Shimada Y, Sato F, Ito T, Kondo K, Watanabe G, Maeda M, Yamasaki S, Meltzer SJ, Imamura M. Prediction of lymph node metastasis with use of artificial neural networks based on gene expression profiles in esophageal squamous cell carcinoma. Ann Surg Oncol 2004;12:1070-8.
25. Luo A, Kong J, Hu G, Liew CC, Xiong M, Wang X, Ji J, Wang T, Zhi H, Wu M, Lin Z. Discovery of Ca2+ -relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 2004;6:1291-9.
26. Zhi H, Zhang J, Hu G, Lu J, Wang X, Zhou C, Wu M, Liu Z. The deregulation of arachidonic acid metabolism-related genes in human esophageal squamous cell carcinoma. Int J Cancer 2003;3:327-33.
27. Truong-Tran AQ, Ho LH, Chai F, Zalewski PD. Cellular zinc fluxes and the regulution of apoptosis/gene-directed cell death. J Nutr 2000;130:1459S-66S.
28. Beyersmann D, Haase H. Functions of zinc in signaling, proliferation and differentiation of mammalian cells. Biometals 2001;14:331-41.
29. Truong-Tran AQ, Carter J, Ruffin RE, Zalewski PD. The role of zinc in caspase activation and apoptotic cell death. Biometals 2001;14:315-30.
30. Maret W. Cellular zinc and redox states converge in the metallothionein/thionein pair. J Nutr 2003;133:1460S-2S.
31. Zalewski PD, Forbes IJ, Betts WH. Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-melhyl-8-p-toluenesulphonamido-6- quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochem J 1993;296:403-8.
32. Chimienti F, Seve M, Richard S, Mathieu J, Favier A. Role of cellular zinc in programmed cell death: temporal relationship between zinc depiction, activation of caspases, and cleavage of Sp family transcription factors. Biochem Pharmacol 2001;62(1):51-62.
33. Vallee BL. Zinc: biochemistry, physiology, toxicology and clinical pathology. Biofactors 1988;1:31-6.
34. Hambidge M. Human zinc deficiency. J Nutr 2000;130:1344S-9S.
35. Prasad AS. Zinc deficiency. BMJ 2003;22:409-10.
36. Fong LY, Nguyen VT, Farber JL. Esophageal cancer prevention in zinc-deficient rats: rapid induction of apoptosis by replenishing zinc. J Natl Cancer Inst 2001;20:1525-33.
37. Foug LY, Mancini R, Nakagawa H, Rustgi AK, Huebner K. Combined cyclin D1 over expression and zinc deficiency disrupts cell cycle and accelerates mouse fore stomach carcinoaenesis. Cancer Res 2003;14:4244-52.
38. Fong LY, Ishii H, Nguyen VT, Vecchione A, Farber JL, Croce CM, Huebner K. p53 deficiency accelerates induction and progression of esophageal and forestomach tumors in zinc-deficient mice. Cancer Res 2003;1:186-95.
39. Lee DH, Anderson KE, Folsom AR, Jacobs DR, Jr. Heme iron, zinc and upper digestive tract cancer: the Iowa Women's Health Study. Int J Cancer 2005;4:643-7.
40. Chimienti F, Aouffen M, Favier A, Seve M. Zinc homeostasis-regulating proteins: new drug targets for triggering cell fate. Curr Drug Targets 2003;4:323-38.
41. Kirschke CP, Huang L. ZnT7, a novel mammalian zinc transporter, accumulates zinc in the Golgi apparatus. J Biol Chem 2003;6:4096-102.
42. Palmiter RD, Huang L. Efflux and compartmemalization of zinc by members of the SLC30 family of solute carriers. Pflugers Arch 2004;5:744-51.
43. Devergnas S, Chimienti F, Naud N, Pennequin A, Coquerel Y, Chantegrel J, Favier A, Seve M. Differential regulation of zinc efflux transporters ZnT-1, ZnT-5 and ZnT-7 gene expression by zinc levels: a real-time RT-PCR study. Biochem Pharmacol 2004;4:699-709.
44. Suzuki T, Ishihara K, Migaki H, Ishihara K, Nagao M, Yamaguchi-Iwai Y, Kambe T. Two different zinc transport complexes of cation diffusion facilitator proteins localized in the secretory pathway operate to activate alkaline phosphatases in vertebrate cells. J Biol Chem 2005;35:30956-62.
45. Suzuki T, Ishihara K, Migaki H, Matsuura W, Kohda A, Okumura K. Nagao M, Yamaguchi-Iwai Y, Kambe T. Zinc transporters, ZnT5 and ZnT7, are required for the activation of alkaline phosphatases, zinc-requiring enzymes that are glycosylphosphatidylinositol-anchored to the cytoplasmic membrane. J Biol Chem 2005;280:637-43.
46. Ishihara K, Yamazaki T, Ishida Y, Suzuki T, Oda K, Nagao M, Yamaguchi-Iwai Y, Kambe T. Zinc transport complexes contribute to the homeostatic maintenance of secretory pathway function in vertebrate cells. J Biol Chem 2006;281(26):17743-50. [Epub ahead of print.]
47. Karin M. Metallothioneins: proteins in search of function. Cell 1985;1:9,10.
48. Szczurek EI, Bjornsson CS, Taylor CG. Dietary zinc deficiency and repletion modulate metallothionein immunolocalization and concentration in small intestine and liver of rats. J Nutr 2001;8:2132-8.
49. Blanchard RK, Moore JB, Green CL, Cousins RJ. Modulation of intestinal gene expression by dietary zinc status: effectiveness of cDNA arrays for expression profiline of a single nutrient deficiency. Proc Natl Acad Sci USA 2001;24:13507-13.
50. Tom Dieck H, Doring F, Roth HP, Daniel H. Changes in rat hepatic gene expression in response to zinc deficiency as assessed by DNA arrays. J Nutr 2003;4:1004-10.
51. Pfaffi MW, Gerstmayer B, Bosio A, Windisch W. Effect of zinc deficiency on the mRNA expression pattern in liver and jejunum of adult rats: monitoring gene expression using cDNA microarrays combined with real-time RT-PCR. J Nutr Biochem 2003;12:691-702.
52. Huang Y, de la Chapelle A, Pellegata NS. Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABPI in papillary thyroid carcinoma. Int J Cancer 2003;6:735-44.
53. Morris MR, Hesson LB, Wagner KJ, Morgan NV, Astuti D, Lees RD, Cooper WN, Lee J, Gentle TD, Macdonald F, Kishida T, Grundy R, Yao M, Latif F, Maher ER. Multigene methylation analysis of Wilms' tumor and adult renal cell carcinoma. Oncogene 2003;43:6794-801.
54. Tokumaru Y, Yamashita K, Osada M, Nomoto S, Sun DI, Xiao Y, Hoque MO, Westra WH, Califano JA, Sidransky D. Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing. Cancer Res 2004;17:5982-7.
55. Henrique R, Jeronimo C, Hoque MO, Nomoto S, Carvalho AL, Costa VL, Oliveira J, Teixeira MR, Lopes C, Sidransky D. MT1G hypermethylation is associated with higher tumor stage in prostate cancer. Cancer Epidemiol Biomarkers Prev 2005;5:1274-8.
56. Yamashita K, Upadhyay S, Osada M, Hoque MO, Xiao Y, Mori M, Sato F, Meltzer SJ, Sidransky D. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2002;6:485-95.
57. Goto E, Ishido S, Sato Y, Ohgimoto S, Ohgimoto K, Nagano-Fujii M, Holta H, c-MIR, a human E3 ubiquitin ligase, is a functional homolog of herpesvirus proteins MIR1 and MIR2 and has similar activity. J Biol Chem 2003;17:14657-68.
58. Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002;62:1613-18.
59. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998;392:190-3.
60. Behrens J, Frixen U, Schipper J, Weidner M, Birchmeier W. Cell adhesion in invasion and metastasis. Semin Cell Biol 1992;3:169-78.
61. Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumor-suppressor gene. Trends Biochem Sci 1999;24:73-6.
62. Uchikado Y, Natsugoe S, Okumura H, Setoyama T, Matsumoto M, Ishigami S, Aikou T. SLUG expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2005;11:1174-80.
63. Yang J, Boerm M, McCarty M, Bucana C, Fidler IJ, Zhuang Y, Su B. Mekk3 is essential for early embryonic cardiovascular development. Nat Genet 2000;3:309-13.
64. Yang J, Lin Y, Guo Z, Cheng J, Huang J, Deng L, Liao W, Chen Z, Liu Z, Su B. The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat Immunol 2001;7:620-4.
65. Samanta AK, Huang HJ, Bast RC, Jr, Liao WS. Overexpression of MEKK3 confers resistance to apoptosis through activation of NFkappaB. J Biol Chem 2004;9:7576-83.
66. Gomez NN, Davicino RC, Biaggio VS, Bianco GA, Alvarez SM, Fischer P, Masnatta L, Rabinovich GA, Gimenez MS. Overexpression of inducible nitric oxide synthase and cyclooxygenase-2 in rat zinc-deficient lung: Involvement of a NF-kappaB dependent pathway. Nitric Oxide 2006;14:30-8.
67. Souza RF. Molecular and biologic basis of upper gastrointestinal malignancy-esophageal carcinoma. Surg Oncol Clin N Am 2002;2: 257-72.
68. Diviani D, Soderling J, Scott JD. AKAP-Lbc anchors protein kinase A and nucleates Galpha 12-selective Rho-mediated stress tiber formation. J Biol Chem 2001;47:44247-57.
69. Sharma R, Samantaray S, Shukla NK, Ralhan R. Transcriptional gene expression profile of human esophageal squamous cell carcinoma. Genomics 2003;5:481-8.
70. Sud N, Sharma R, Ray R, Chattopadhyay TK, Ralhan R. Differential expression of G-protein coupled receptor 56 in human esophageal squamous cell carcinoma. Cancer Lett 2006;233:265-70.
71. Lewis TE, Milam TD, Klingler DW, Rao PS, Jaggi M, Smith DJ, Hemstreet GP, Balaji KC. Tissue transglutaminase interacts with protein kinase A anchor protein 13 in prostate cancer. Urol Oncol 2005; 23:407-12.
72. Mehta K, Fok J, Miller FR, Koul D, Sahin AA. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer. Clin Cancer Res 2004;23:8068-76.
73. Stephens P, Grenard P, Aeschlimann P, Langley M, Blain E, Errington R, Kipling D, Thomas D, Aeschlimann D. Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. J Cell Sci 2004;117:3389-403.
74. Mangala LS, Arun B, Sahin AA, Mehta K. Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion. Mol Cancer 2005;4:33.
75. Overall CM, Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2002;9:657-72.
76. Le Du MH, Stigbrand T, Taussig MJ, Menez A, Stura EA. Crystal structure of alkaline phosphatase from human placenta at 1.8 A resolution. Implication for a substrate specificity. J Biol Chem 2001;276: 9158-65.
77. Samantaray S, Sharma R, Chattopadhyaya TK, Gupta SD, Ralhan R. Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2004;130:37-44.
78. Sharma R, Chattopadhyay TK, Mathur M, Ralhan R. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer. Oncology 2004;67:300-9.